Brachial artery endothelial function predicts platelet function in control subjects and in patients with acute myocardial infarction

Platelets

Volumn 23, Issue 3, 2012, Pages 202-210

  Shechter, Michael ^a,b   Shechter, Alon ^a,b   Hod, Hanoch ^a,b   Fefer, Paul ^a,b   Shenkman, Boris ^a,b   Koren Morag, Nira ^b   Feinberg, Micha S ^a,b   Harats, Dror ^a,b   Ami Sela, Ben ^a,b   Savion, Naphtali ^a,b   Varon, David ^c   Matetzky, Shlomi ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Endothelial function; Endothelium; Myocardial infarction; Nitric oxide; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPERTENSION; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SMOKING HABIT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VASODILATATION;

ADULT; AGED; ARTERIES; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; PLATELET FUNCTION TESTS; VASODILATION; VASODILATOR AGENTS;

EID: 84859766262     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.604805     Document Type: Article

References (37)

1. Lerman A, Zeiher AM. Endothelial function. Circulation 2005;111:363-368.
2. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986;88:411-415.
3. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987;90:687-692.
4. Bhardwaj R, Page CP, May GR, Moore PK. Endotheliumderived relaxing factor inhibits platelet aggregation in human whole blood in vitro and in the rat in vivo. Eur J Pharmacol 1988;157:83-91.
5. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res 1989;65:1798-1803.
6. Cominacini L, Zatti M, Lechi A. Oxidized LDL and the reduction of the antiaggregating activity of nitric oxide derived from endothelial cells. Thromb Haemost 1995;74:1175-1179.
7. Diodati JG, Dakak N, Gilligan DM, Quyyumi AA. Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation 1998;98:17-24.
8. Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Asp Med 2005;26:33-65.
9. Widlansky ME, Gokce N, Keaney J, Vita JA. The clinical implication of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160.
10. Shechter M, Sharir M, Paul Labrador M, Forrester J, Merz CN. Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels below 100 mg/dL. Am J Cardiol 2000;86:1256-1259.
11. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000;102:2353-2358.
12. Freimark D, Feinberg SM, Matetzky S, Hochberg N, Shechter M. The impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure. Am Heart J 2004;148:878-882.
13. Shechter M, Matetzky S, Feinberg MS, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003;42:2090-2095.
14. Shechter M, Beigel R, Freimark D, Matetzky S, Feinberg MS. Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. Am J Cardiol 2006;97:1650-1653.
15. Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 2009;11:588-593.
16. Talia L, Karasik A, Feinberg MS, Shechter M. The acute effect of various glycemic index dietary carbohydrates on endothelial function in normoglycemic subjects. J Am Coll Cardiol 2009;53:2283-2287.
17. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, et al. Guidelines for ultrasound assessment of endothelial-dependent flowmediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265.
18. Varon D, Dardik R, Shenkman B, Kotev-Emeth S, Farzame N, Tamarin I, Savion N. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997;85:283-294.
19. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-2913.
20. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005;45:246-251.
21. Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M. Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 2003;89:783-787.
22. Matetzky M, Shenkman B, Guetta V, Shcechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004;109:3064-3067.
23. Cuisset T, Frere C, Quilici J, Barbou F, Morange PE, Hovasse T, Bonnet JL, Alessi MC. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 2006;4:542-549.
24. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Grandada J, DeLao T, Bray PF, Kleiman NS. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance. J Am Coll Cardiol 2006;47:27-33.
25. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, Bassi AK, Tantry US. Platelet reactivity in patients and recurrent events post-stenting: Results of the PREPARE POST-STENTING study. J Am Coll Cardiol 2005;46:1820-1826.
26. Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA. Surrogate markers for cardiovascular disease-functional markers. Circulation 2004;109(suppl IV):IV31-IV46.
27. Gokce N, Keaney Jr JF, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002;105:1567-1572.
28. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-658.
29. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Mü nzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-2678.
30. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-196.
31. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-1906.
32. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Non-invasive detection of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995;74:247-253.
33. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:111-115.
34. Cowley AJ, Stainer K, Cockbill S, Heptinstall S. Correlation between platelet behavior and cold-induced vasoconstriction in man, and the effects of epoprostenol infusion. Clin Sci 1984;67:511-514.
35. Cowley AJ, Heptinstall S, Mitchell JRA. Similarity between platelet and blood-vessel reactivity. Lancet 1985;2:154-155.
36. Heitzer T, Rudolph V, Schwedhelm E, Karstens M, Sydow K, Ortak M, Tschentscher P, Meinertz T, Böger R, Baldus S. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease. Evidence for antioxidant and anti-inflammatory effects. Arterioscler Thromb Vasc Biol 2006;26:1648-1652.
37. Warnholtz A, Ostad MA, Velich N, Trautmann C, Schinzel R, Walter U, Munzel T. A single loading dose of clopidogrel cause dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: Results of a double-blind, randomized study. Athrosclerosis 2008;196:689-695.